Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
16 participants
INTERVENTIONAL
2017-09-14
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active protein drink
Active protein drink
Active protein drink
Fish protein from cod to be used for man after Heavy excercise to restitute
Placebo drink
Placebo drink
Active protein drink
Fish protein from cod to be used for man after Heavy excercise to restitute
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active protein drink
Fish protein from cod to be used for man after Heavy excercise to restitute
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The subject is a man between 40-50 years
* The subject has a body mass index (BMI) between 19-29
* Willing to comply with all study procedures and be available for the length of the study
* In good general health as judged by the physician at the screening visit
Exclusion Criteria
* Diabetes type 1 or 2, or persistent high blood sugar levels
* The subject has tested positive for human immunodeficiency virus (HIV)
* Hepatitis B surface antigen (HBsAg), or hepatitis C virus antibody (anti-HCV)
* The subject has taken any investigational drugs within 1 month prior to screening
* Treated with antibiotics within 3 months prior to screening (oral, parenteral or rectal), but not spray or ointment
* Treated with steroids within 1 month prior to screening (including oral treatment)
* Treated with medication that effects the intestinal function such as, H2- protonpump inhibitors, diuretics, antiemetics, antidepressants, antacids,
40 Years
50 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Firmenich Bjørge Biomarine As
UNKNOWN
Haukeland University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Haukeland University Hospital
Bergen, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Trygve Hausken, MD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Mjos I, Thorsen E, Hausken T, Lied E, Nilsen RM, Bronstad I, Edvardsen E, Frisk B. The effect of low dose marine protein hydrolysates on short-term recovery after high intensity performance cycling: a double-blinded crossover study. J Int Soc Sports Nutr. 2019 Oct 29;16(1):48. doi: 10.1186/s12970-019-0318-3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017/56
Identifier Type: -
Identifier Source: org_study_id